Some aspects of thyroid dysfunction in thalassemia major patients with severe iron overload

被引:0
|
作者
Rindang, Cynthia K. [1 ]
Batubara, Jose R. L. [1 ]
Amalia, Pustika [1 ]
Satari, Hindra [1 ]
机构
[1] Univ Indonesia, Cipto Mangunkusumo Hosp, Med Sch, Dept Child Hlth, Jl Salemba 6, Jakarta, Indonesia
关键词
thalassemia major; endocrine; primary hypothyroidism; iron overload; iron chelation therapy;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Severe iron overload due to recurrent transfusions for chronic anemia and inadequate iron chelation therapy in thalassemia major patients result in various complications, including hypothyroidism. Currently, there has been no data on the prevalence of hypothyroidism in thalassemia major patients at the Thalassemia Centers, Department of Child Health, Cipto Mangunkusumo Hospital (DCH CMH). Objective To study the prevalence of primary hypothyroidism in thalassemia major patients in the Thalassemia Center, DCH MCH. Methods We performed a cross-sectional, descriptive study. All thalassemia major subjects aged 0-18 years with severe iron overload underwent thyroid function examination. Primary hypothyroidism was defined as either normal (compensated) or decreased (decompensated) free T4 (FT4) levels, along with elevated sensitive thyroid-stimulating hormone (TSH) Results 179 subjects enrolled this study with male: female ratio of 1:1.6. The prevalence of primary hypothyroidism in thalassemia major patients with severe iron overload was 26.8% (48/179). Of those 48, 45 had compensated hypothyroidism and 3 had decompensated hypothyroidism, 25.1% and 1.7% of the total subjects, respectively. Compensated hypothyroidism was observed in 17 subjects aged <10 years and in 28 subjects aged >10 years. All 3 decompensated hypothyroidism cases were > 10 years of age. No relationship was found between the occurrence of primary hypothyroidism and mean pre-transfusion Hb levels (P=0.481, OR 1.30; 95% CI 0.63 to 2.68), elevated serum ferritin levels (P-0.74, OR a89; 95% CI 0.46 to L75), and compliance to iron chelation therapy (P=0.570, OR 0.76; 95% CI 0.35 to 1.65). Based on multivariate analysis, only age of < 10 year-old (P=0.029, OR 0.469; 95% CI 0.23 to 0.93) was significantly associated with primary hypothyroidism. Further analysis using receiver operator curve (ROC) technique found that age of 8.5 year-old was the cutoff value to predict the risk of hypothyroidism. Conclusion The prevalence of primary hypothyroidism in our study is high. The occurrence of hypothyroidism is associated with age.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 50 条
  • [41] Iron overload and liver function in patients with beta thalassemia major: A cross sectional study
    Faruqi, Amna
    Zafar, Tooba
    Subuctageen, Sikander
    Mughal, Irfan Afzal
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2024, 40 (09) : 2000 - 2004
  • [42] Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload
    John-Paul Carpenter
    Francisco Alpendurada
    Monica Deac
    Alicia Maceira
    Maciej Garbowski
    Paul Kirk
    J Malcolm Walker
    John B Porter
    Farrukh Shah
    Winston Banya
    Taigang He
    Gillian C Smith
    Dudley J Pennell
    Journal of Cardiovascular Magnetic Resonance, 12
  • [43] Cardiac MR images of thalassemia major patients with myocardial iron overload: a data note
    Emad Shiae Ali
    Mohamad Amin Bakhshali
    Seyed Jafar Shoja Razavi
    Hoorak Poorzand
    Parvaneh Layegh
    BMC Research Notes, 14
  • [44] The Effect of HFE Polymorphisms on Cardiac Iron Overload in Patients with Beta-Thalassemia Major
    Turedi, Aysen
    Oymak, Yesim
    Mese, Timur
    Yaman, Yontem
    Bayraktaroglu, Selen
    Alpman, Asude
    Ozkinay, Ferda
    Aydinok, Yesim
    Vergin, Canan
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2013, 30 (08) : 755 - 760
  • [45] Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload
    S. Daar
    A. V. Pathare
    Annals of Hematology, 2006, 85 : 315 - 319
  • [46] INCREASING IRON OVERLOAD FOLLOWING SPLENECTOMY IN BETA THALASSEMIA MAJOR
    Chung, Jong
    Lal, Ashutash
    Vichinsky, Elliott
    PEDIATRIC BLOOD & CANCER, 2012, 58 (07) : 1076 - 1076
  • [47] Sequential Deferoxamine - Deferasirox in Treatment of Major Thalassemia with Iron Overload
    Keikhaei, B.
    IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2010, 1 (01) : 14 - 18
  • [48] Hemostatic abnormalities in children with thalassemia major and liver iron overload
    Wahidiyat, Pustika Amalia
    Iskandar, Stephen Diah
    Chozie, Novie Amelia
    Sekarsari, Damayanti
    PAEDIATRICA INDONESIANA, 2018, 58 (04) : 175 - 179
  • [49] Evaluation of Hepatic Iron Overload in Chinese Children With β-Thalassemia Major
    Xu, Lu-Hong
    Fang, Jian-Pei
    Xu, Hong-Gui
    Weng, Wen-Jun
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 28 (08) : 702 - 707
  • [50] Genetic modifiers of secondary iron overload in beta thalassemia major
    Athiyarath, Rekha
    George, Biju
    Abraham, Aby
    Viswabandya, Auro
    Srivastava, Alok
    Edison, Eunice Sindhuvi
    BLOOD CELLS MOLECULES AND DISEASES, 2015, 54 (03) : 242 - 243